We the undersigned civil society organizations urge your companies to uphold the right to freedom of expression of your users in Türkiye and resist Turkish state censorship that restricts expression ...

AB Science SA (Euronext - FR0010557264 - AB) today reports its revenues for the year 2024 and provides an update on its activities. CLINICAL DEVELOPMENT KEY EVENTS DURING THE YEAR 2024 AND SINCE ...

With 90% of the country’s media now controlled by the state, it is becoming harder and harder to report independently ...

The fact that investigations were launched into 55 journalists, columnists, and reporters over a three-month period shows how ...

From damning recordings to unexpected DNA evidence, these crucial pieces of evidence left no room for doubt. Join us as we ...

“I don’t, we don’t have a choice. We can’t sit around waiting for the courts to do something. We have to do something, and we ...

Or it seems that after the recent court win and appeal win that looks like ... based on the fact that it is a materially different BTK from the other BTKs that are out there.

Newer-generation Bruton's tyrosine kinase (BTK) inhibitors have found a place in the management of follicular lymphoma, a malignancy where the first-generation drug ibrutinib (Imbruvica ...

LONDON, England—A recently approved drug-eluting bioresorbable scaffold for the treatment of below-the-knee (BTK) chronic limb-threatening ischemia (CLTI) is highly likely to be cost-effective for ...